Amneal Pharmaceuticals, Inc. reports

Company location: Bridgewater, NJ
Fiscal year end: 31 December

Amneal Pharmaceuticals, Inc. has filed 691 SEC EDGAR filings since 21 Nov 2017

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 351-375 of 691 matching filings.

Per page

25

Current page

15

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 03 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 03 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 03 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3ASR File 333-263226

S-3ASR

Filing date: 02 Mar 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3ASR File 333-263225

S-3ASR

Filing date: 02 Mar 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38485

8-K

Filing date: 02 Mar 2022
Reporting date: 02 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 01 Mar 2022
Reporting date: 27 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 01 Mar 2022
Reporting date: 27 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 01 Mar 2022
Reporting date: 27 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-38485

10-K

Filing date: 01 Mar 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-90473

SCHEDULE 13G/A

Filing date: 09 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 26 Jan 2022
Reporting date: 17 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 - AMNEAL PHARMACEUTICALS INC.

Filing date: 21 Jan 2022
Reporting date: 12 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-90473

AMENDED SC13D

Filing date: 19 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38485

8-K

Filing date: 11 Jan 2022
Reporting date: 11 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38485

FORM 8-K

Filing date: 05 Jan 2022
Reporting date: 30 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Dec 2021
Reporting date: 17 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 17 Dec 2021
Reporting date: 15 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 17 Dec 2021
Reporting date: 15 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 17 Dec 2021
Reporting date: 15 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Dec 2021
Reporting date: 02 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .